These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 2684521)
1. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials. Sobota JT Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519 [No Abstract] [Full Text] [Related]
2. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin. Brunner R; Pollok M; Heidel M; Müller R; Degenhardt S; Baldamus CA Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784 [No Abstract] [Full Text] [Related]
4. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis. Korbet SM Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832 [No Abstract] [Full Text] [Related]
5. The adverse effects of recombinant human erythropoietin therapy. Wong KC; Li PK; Lui SF; Nicholls MG; Lai KN Adverse Drug React Acute Poisoning Rev; 1990; 9(4):183-206. PubMed ID: 2088088 [No Abstract] [Full Text] [Related]
6. The long-term effects of recombinant human erythropoietin on the cardiovascular system. Eschbach JW; Aquiling T; Haley NR; Fan MH; Blagg CR Clin Nephrol; 1992; 38 Suppl 1():S98-103. PubMed ID: 1295715 [TBL] [Abstract][Full Text] [Related]
7. Erythropoietin-induced hypertension. Ismail N; Ikizler TA J Med Liban; 1997; 45(1):25-30. PubMed ID: 9421942 [No Abstract] [Full Text] [Related]
8. [Erythropoietin, a milestone in the history of nephrology]. Uehlinger DE; Frey FJ Ther Umsch; 1995 Oct; 52(10):672-7. PubMed ID: 7482378 [TBL] [Abstract][Full Text] [Related]
9. Erythropoietin and arterial hypertension. Luft FC Clin Nephrol; 2000 Feb; 53(1 Suppl):S61-4. PubMed ID: 10746808 [TBL] [Abstract][Full Text] [Related]